Loading company details...
Beta
Latest Form 4 (Oct 17, 2026): John M. Evans (CEO): Exercise/Conversion of 25,000 shares, $25.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 17, 2026 | John M. Evans, CEO | Exercise/Conversion | 25,000 | $25.8K |
| Oct 2, 2026 | Bethany J. Cavanagh, SVP, Finance and Treasurer | Sale | 187 | $4.6K |
| Sep 25, 2026 | Giuseppe Ciaramella, President | Gift | 123,407 | n/a |
| Jul 29, 2026 | Amy Simon, Chief Medical Officer | Sale | 16,667 | $429.0K |
| Jul 2, 2026 | Amy Simon, Chief Medical Officer | Sale | 373 | $13.0K |
| Jul 1, 2026 | John M. Evans, CEO | Exercise/Conversion | 18,663 | $12.5K |
| Jun 29, 2026 | FMR LLC | Sale | 33,372 | $1.17M |
| Jun 22, 2026 | Giuseppe Ciaramella, President | Exercise/Conversion | 6,505 | $4.4K |
| Jun 5, 2026 | Christi Shaw | Grant/Award | 19,676 | n/a |
| Jun 5, 2026 | Kathleen E. Walsh | Grant/Award | 19,676 | n/a |